Ascendis Pharma A/S (ASND)
NASDAQ: ASND · IEX Real-Time Price · USD
148.44
-1.52 (-1.01%)
Mar 27, 2024, 4:00 PM EDT - Market closed

Ascendis Pharma Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2012
Net Income
-481.45-583.19-383.58-418.96-218.02-130.1-123.9-68.51-32.92-9.66
Upgrade
Depreciation & Amortization
18.9117.9615.399.456.690.880.730.680.560.5
Upgrade
Share-Based Compensation
66.6664.1866.8353.1737.4919.659.717.321.711.27
Upgrade
Other Operating Activities
-71.495.36-116.2984.79-2.1-29.2418.360.33-12.82-10.52
Upgrade
Operating Cash Flow
-467.36-495.7-417.65-271.55-175.94-138.8-95.1-60.18-43.47-18.4
Upgrade
Capital Expenditures
-2.39-4.95-24.23-16.5-5.16-2.65-0.94-0.67-1.04-0.41
Upgrade
Acquisitions
00-10.190000000
Upgrade
Change in Investments
288.8766.69-76.16-274.7000000
Upgrade
Investing Cash Flow
286.4761.73-110.58-291.2-5.16-2.65-0.94-0.67-1.04-0.41
Upgrade
Share Issuance / Repurchase
10.29-100.15357.82607.42497.63216.39133.11125.97114.1448.1
Upgrade
Debt Issued / Paid
125.82496.93-6.43-4.77-4.0400000
Upgrade
Other Financing Activities
-1.81-----13.12-8.39-8.5-8.4-0.19
Upgrade
Financing Cash Flow
134.29396.77351.39602.65493.59203.27124.72117.46105.7447.91
Upgrade
Exchange Rate Effect
-6.0135.6938.59-53.497.7520.69-13.664.078.251.64
Upgrade
Net Cash Flow
-46.6-37.19-176.8439.9312.561.8228.6856.6161.2429.1
Upgrade
Free Cash Flow
-469.75-500.65-441.88-288.05-181.1-141.45-96.04-60.85-44.51-18.81
Upgrade
Free Cash Flow Margin
-176.12%-978.33%-5681.19%-4142.76%-1353.98%-1336.83%-6277.12%-1321.12%-548.23%-134.51%
Upgrade
Free Cash Flow Per Share
-8.35-8.93-8.07-5.69-3.89-3.44-2.86-2.29-1.87-1.65
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).